Search
Civorebrutinib
go.drugbank.com/drugs/DB21641ExperimentalCivorebrutinib has a monoisotopic molecular weight of 463.15 Da.
Regadenoson
go.drugbank.com/drugs/DB06213ApprovedInvestigationalRegadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008.
Categories: Purinergic P1 Receptor AgonistsOlodaterol
go.drugbank.com/drugs/DB09080ApprovedInvestigationalA once-a-day treatment with a LABA has several advantages over short-acting bronchodilators and twice-daily LABAs including improved convenience and compliance and improved airflow over a 24-hour period
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 SubstratesZavacorilant
go.drugbank.com/drugs/DB21509InvestigationalZavacorilant has a monoisotopic molecular weight of 555.15 Da.
Neladalkib
go.drugbank.com/drugs/DB21712InvestigationalNeladalkib has a monoisotopic molecular weight of 452.15 Da.
Xiliertinib
go.drugbank.com/drugs/DB21453InvestigationalXiliertinib has a monoisotopic molecular weight of 442.21 Da.
Paltimatrectinib
go.drugbank.com/drugs/DB21588InvestigationalPaltimatrectinib has a monoisotopic molecular weight of 434.13 Da.
Capmatinib
go.drugbank.com/drugs/DB11791ApprovedInvestigationalL13347] The presence of the mutation must be confirmed by an FDA-approved test, such as the FoundationOne CDx assay (manufactured by Foundation Medicine, Inc.), which was approved by the FDA on the same day
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesEvifacotrep
go.drugbank.com/drugs/DB21510InvestigationalEvifacotrep has a monoisotopic molecular weight of 441.06 Da.
Zosurabalpin
go.drugbank.com/drugs/DB21539InvestigationalZosurabalpin has a monoisotopic molecular weight of 790.36 Da.